New hope for kids with tough liver cancer: immune therapy trial opens
Disease control
Recruiting now
This study is testing whether an immunotherapy drug called pembrolizumab (KEYTRUDA®) can help control liver cancer that has come back or hasn't responded to other treatments in children and young adults. The trial will enroll up to 18 participants under age 30 to see if the drug …
Phase: PHASE2 • Sponsor: Allison O'Neill, MD • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC